Pseudomonas aeruginosa is a prevalent and pernicious pathogen equipped with both extraordinary 23 capabilities to infect the host and to develop antimicrobials resistance (AMR). Monitoring the 24 emergence of AMR high risk clones and understanding the interplay of their pathogenicity and 25 antibiotic resistance is of paramount importance to avoid resistance dissemination and to control 26 P. aeruginosa infections. In this study, we report the identification of a multidrug resistant (MDR) 27 P. aeruginosa strain PA154197 isolated from a blood stream infection in Hong Kong. PA154197 28 belongs to a distinctive MLST550 clonal complex shared by two international P. aeruginosa 29 isolates VW0289 and AUS544. Comparative genome and transcriptome analysis with the 30 reference strain PAO1 led to the identification of a variety of genetic variations in antibiotic 31 resistance genes and the hyper-expression of three multidrug efflux pumps MexAB-OprM, 32 MexEF-OprN, and MexGHI-OpmD in PA154197. Unlike many resistant isolates displaying an 33 attenuated virulence, PA154197 produces a significantly high level of the P. aeruginosa major 34 virulence factor pyocyanin (PYO) and displays an uncompromised virulence compared to PAO1. 35 Further analysis revealed that the secondary quorum sensing system Pqs which primarily controls 36 the PYO production is hyper-active in PA154197 independent of the master QS systems Las and 37 Rhl. Together, these investigations disclose a unique, uncoupled QS mediated pathoadaptation 38 mechanism in clinical P. aeruginosa which may account for the high pathogenic potentials and 39 antibiotics resistance in the MDR isolate PA154197. 40 41 Pseudomonas aeruginosa is a ubiquitous Gram-negative pathogen that causes a variety of 42 notorious infections in humans such as ventilator-associated pneumonia, lung infections of cystic 43 fibrosis (CF) patients, burn wound infection, and various sepsis syndromes. It is the second leading 44 cause of hospital-acquired infections and is especially problematic in ICUs, where it is the leading 45 cause of pneumonia among pediatric patients and is responsible for a large number of urinary tract 46 (10% in US and 19% in Europe), blood stream (3% in US and 10% in Europe), eye, ear, nose, and
Introduction
. Inter-patient spread of antibiotic resistant mutations linked to the transmission of 87 epidemic CF strains is also reported. These clones are denominated as international high-risk 88 clones. Among them, the most recognized successful clones are the high risk MDR clones ST111, 89 ST175, and ST235, and the Liverpool Epidemic Strain (LES) ST146, which is the most epidemic 90 clone among CF patients (11) . Further deeper analysis of the molecular details of their resistance 91 development and closely monitoring of the emerging of new international MDR/XDR high risk 92 clones are of paramount importance to avoid the world-wide dissemination of these clones and to 93 control P. aeruginosa infections.
95
In addition to their broad and high level of antibiotic resistance, many MDR clones, especially the 96 three major international high risk clones ST111, ST175, ST235, are found to be associated with 97 a defined set of biological markers which include defective motility (swimming, swarming, and 98 twitching), reduced pigment production (pyocyanin and pyoverdine), reduced in vitro fitness, but 99 enhanced biofilm formation (5, 11) . These suggest the presence of a fitness trade-off that 100 compromises the pathogenic potentials and virulence of MDR isolates. Several epidemiological 101 survey and molecular evolutionary studies ascribed these phenotypes to quorum sensing (QS) for PAO1 ( Fig. 1A) . We found that PA154197 displays resistance to almost all these different 133 classes of antibiotics with a 4-, 16-, 80-, and 160-fold decreases in susceptibility to the common 134 antipseudomonal drugs ATM, IPM, CIP, and LVX, respectively, compared to PAO1. The only 135 two antibiotics it remains susceptible are the aminoglycoside amikacin and the cyclic non-136 ribosomal polypeptides polymyxin B and E, which meets the XDR criteria (resistance to all but 137 one or two of the eight classes of antipseudomonal drugs) according to Magiorakos et. al (16) . To 138 further evaluate its resistance level, we compared the antibiotics susceptibility profile of PA154197 139 with the three international high-risk clones using the published data (25) and found that 140 PA154197 displays a comparable resistance profile with the high-risk clone ST175 (Fig. 1B) , 141 highlighting the high epidemic and risk potential of PA154197.
143
Sequencing type, phylogenetic position, and genomic islands of PA154197 144 We then sequenced the genome of PA154197 which resulted in one single circular chromosome 145 with a length of 6,445,239 bp and a GC content of 66.38%. A total number of 5,923 genes are 146 predicted in PA154197 genome which include 5,816 coding gene sequences (CDS), 26 pseudo-147 genes, 12 rRNA, 65 tRNA and 4 ncRNA (Table 1) . Based on PubMLST, PA154197 is assigned 148 to the multilocus sequence typing (MLST) 550, a clonal complex which is currently shared by two 149 additional clinical isolates, VW0289 and AUS544 from the CF patients in the Netherland and 150 Australia, respectively ( Fig. 2A ), but the complete genome sequences of these two strains are 151 unavailable. PAst analysis revealed that PA154197 belongs to the Serotype O9 (26) ( Table 1) .
152
Analyzing its accessory genome identified 21 genome islands (GIs) including 3 prophages (Table   153   S1 ). In addition to hypothetical proteins, a large number of metabolic enzymes such as 154 oxidoreductase, oxygenase and halogenase, as well as the AraC and LysR type transcription 155 regulators are encoded in these GIs, implying the potential roles of the accessory genome of 156 PA154197 in the adaptation and fitness of the bacterium. synonymous mutations, G71-E, E153-Q, S209-R, are identified in the nalC gene in PA154197 179 (Table 2) .
181
New genomic variations that potentially lead to antibiotic resistance is also identified in 182 PA1541197, such as a 6-bp deletion (corresponding to the deletion of E959 and S969) in the C-183 terminal of GyrA and a E76-*(stop codon) mutation in the mexR gene which will lead to pre- the antibiotic resistance genes is provided in Table 2 . 193 194 
Expression of the resistance genes and the functional genome of P. aeruginosa PA154197

195
To examine the resistance mechanisms of PA154197 especially the expression levels of the 196 resistance genes identified, we performed a comparative transcriptome analysis on PA154197 and 197 the reference strain PAO1 using RNA-seq. Among the 5,543 orthologous genes identified in the 198 two strains using progressiveMauve (32), differential expression of 3,148 genes are observed and 199 their expression levels are compared using DESeq (33) ( Fig. 3 and Table S2 ). Notably, among the 200 genes which display significantly higher expression levels in PA154197 than in PAO1, those 201 encoding four efflux pumps, such as mexEF-oprN (PA2493-PA2495), mexRAB-oprM (PA0424-202 PA0427), mexGHI-opmD (PA4205-PA4208), and mexKJL (PA3676-PA3678) are observed (Fig. 203 3), consistent with the MDR profile of PA154197. Genes that confer resistance to specific 204 antibiotics, such as that of ampC, gyrA, gyrB, and parC, parE, are not differentially expressed in 205 the RNA-Seq analysis, suggesting that over-expression of several multidrug efflux pumps may 206 play a major role in the MDR development in PA154197. COG functional distribution analysis of 207 the differentially expressed genes also reveals the enrichment of efflux pump genes among all the 208 genes which are expressed at a higher level in PA154197 than in PAO1 ( Fig S1) .
209
To verify the relative expression levels of these genes in the two strains, we conducted RT-qPCR 210 analysis. As shown in Fig 4B, consistent with the RNA-Seq data, the MexEF-OprN efflux system 211 displayed the most significant higher expression (265-574 fold) in PA154197 than in PAO1, 212 followed by the MexGHI-OpmD (8.5-41.9 fold) and the MexAB-OprM (4.6-11 fold) efflux system.
213
On the other hand, another efflux system which over-expression is associated with 214 aminoglycosides resistance, the MexXY-OprD system, did not show increased relative expression 215 in PA154197 in either RNA-Seq or the RT-qPCR analysis, consistent with the fact that PA154197 216 remains susceptible to the aminoglycoside antipseudomonal drug amikacin (Fig 1) . Overall, an EB 217 efflux assay showed the hyper-efflux activity in PA154197 than in PAO1 ( Fig 4C) , suggesting that 
Virulence of P. aeruginosa PA154197
Our comparative transcriptome analysis also reveals a significantly higher expression of several 225 virulence genes in PA154197 than in PAO1 (Fig 3 and Table S2 ). These include the type III (psc 226 genes) and the type VI (tss and hcp-1 genes) secretion systems, pyocyanin production (phz genes), 227 the PQS quorum sensing system (pqs genes), and a series of Fe and heme acquisition genes (fep 228 and has genes). On the other hand, several genes involved in biofilm formation (such as psl, alg, 229 lecA), motility, pili and fimbrial assembly proteins (such as cup genes), and pyoverdine production 230 (pvd genes) are expressed at a lower level in PA154197 than in PAO1.
231
To examine the virulence factors production and the virulence of PA154197, we examined 232 pycyanin (PYO) and pyoverdine production, swimming and swarming motilities, and biofilm 233 formation of PA154197 and compared with that of PAO1. As shown in Fig 5, PA154197 cells 234 display a significantly higher PYO production than PAO1 cells when grown on both LB plate and 235 in LB liquid broth ( Fig 5A) . In contrast, PA154197 displays reduced pyoverdine production 236 compared to PAO1 ( Fig 5B) . Consistent with the lower expression of biofilm genes in PA154197 237 than in PAO1, PA154197 displays a reduced biofilm formation capability as examined by the 238 crystal violet staining ( Fig. 5C ). In terms of the motility of the bacterium, PA154197 displays a 239 comparable swimming activity with that of PAO1, but a defective swarming motility ( Fig. 5D ) 240 which is consistent with the lower expression of the pili and fimbria assembly genes in this strain.
241
To evaluate the in vivo virulence of PA154197, we conducted Caenorhabditis elegans fast killing 242 and slow killing assays which are established infection models to evaluate the cytotoxicity and 243 pathogenicity of P. aeruginosa, respectively(34). We found that the two strains display a 244 comparable cytotoxicity and pathogenicity (virulence) (Fig. 5E ) to the C. elegans host. Together, 245 these studies indicate that PA154197 over-expresses a subset of virulence factors and does not 246 display a compromised virulence as reported for many other resistant strains.
247
The Pqs quorum sensing system is activated in PA154197 independent of the primary QS system 249 250 It is known that three hierarchically organized QS systems, Las, Rhl, and Pqs, regulate the 251 production of an arsenal of virulence factors in P. aeruginosa with each being primarily associated 252 with the elastase (encoded by lasB gene), rhamnolipid (encoded by rhlA gene) and pyocyanin 253 (encoded by phz genes) production, respectively (35, 36) ( Fig 6A) . Among them, the Las system PA154197 than in PAO1, whereas genes controlled by Pqs, such as phZ genes, pqsA-E, and phnAB 265 are expressed in a significantly higher level in PA154197 than in PAO1 ( Fig 6A and Table S2 ).
Las and Rhl
266
RT-qPCR analysis confirmed this observation ( Fig 6B) . These data suggest that the secondary QS As a successful and ubiquitous pathogen, P. aeruginosa is equipped with extraordinary 273 machineries to adapt to the host environments and antibiotic therapies to survive and disseminate. Several previous studies reported QS deficiency in antibiotic resistant clinical isolates and 292 attributed the attenuated virulence of the strains to this mechanism, as these mutants are proposed 293 to be social cheaters that exploit shared QS products without incurring metabolic costs to 294 themselves (18-21). However, majority of these studies were based on comparative genomic 295 analysis to identify mutations in the QS system genes, and the identified variations were mainly 296 found in the master QS regulator LasR, including both lasR-null and various lasR point mutations.
297
Consistently, the identified strains often display an overall QS-inactivation phenotype, such as 298 decreased production of all the major QS regulated virulence factors including elastase, 299 rhamnolipids, pyoverdine, pyocyanin. Different from these lasR defective isolates, PA154197 300 produces a significantly higher amount of PYO, a major virulence factor secreted by P. aeruginosa 301 (37), and other Pqs regulated gene products than PAO1, while a lower level of Las and Rhl 302 regulated virulence factors and genes than in PAO1. This uncoupled activation of Pqs system 303 ensures the production of a major virulence factor PYO with minimal metabolic burden, thus is 304 beneficial to the fitness and virulence of the pathogen. How P. aeruginosa achieves this differential 305 activation is not known currently. We compared the promoter regions of the lasRI, rhlRI, pqsR, 306 and pqsA-E operons with the corresponding sequences in PAO1, but did not find any nucleotide 307 alternations that may account for the differential activation of pqs genes. Comparative genomics 308 analysis revealed a point mutation Q98P in PA154197 LasR which is located at the α5 of the N-3-309 oxo-dodecanoyl-homoserine lactone binding domain of the protein but the residue is not located 310 in the binding pocket (38). Whether this point mutation leads to differential activation of the Pqs 311 system warrants further investigations. Notably, Las independent activation of a downstream QS 312 system was also reported in a collection of P. aeruginosa isolates from CF patients in which half 313 of the lasR-null strains were found to retain the RhlR activity (20). Hence, adaptable QS hierarchy 314 which uncouples a downstream QS system from the master regulator LasR may represent an 315 emerging compensatory mechanism that facilitates the fitness, virulence, and persistence of P. aeruginosa in the host settings.
318
With the increasing frequency of detecting the MDR P. aeruginosa isolates from various sources, 319 it is recognized that the resistance traits of a strain are often the result of a complex interaction of 320 several cellular processes and no individual mutation or resistance gene is sufficient to confer 321 clinically significant resistance (39, 40) . In this study, we identified multiple genetic variations MexGHI in PA154197, but the expression of ampC and gyrA was found to be in a similar level to 328 that in PAO1. Whether these two genes contribute to the profile and level of resistance exhibited 329 in PA154197 remains further molecular validation. Notably, both the T105A mutation in AmpC 330 and T83I mutation in GyrA are the well characterized genetic variants associated with antibiotic 331 resistance, which have been termed as the PDC-3 type AmpC variant (28) and the quinolone 332 resistance-determining region (QRDR) hotspot mutation, respectively (14). However, these two 333 mutations are also identified in other P. aeruginosa isolates we surveyed such as PA150577 which 334 does not display resistance to β-lactams or fluoroquinolones (data not shown). Hence, the observed 335 resistance to antipseudomonal aztreonam (monobactam) and imipenem (carbepenam) in 336 PA154197 may not be due to the T105A mutation in AmpC, and the observed resistance to 337 ciprofloxacin and levofloxacin (fluoroquinolone) may not be due to the T83I mutation in GyrA.
338
In addition, acquiring additional and extended-spectrum β-lactamase on mobile genetic elements 339 represents another common mechanism of β-lactam resistance in P.aeruginosa (41) Genomic DNA extraction 361 Extraction of the genomic DNA of PA154197 was performed following the description in a previous study (44). Briefly, PA154197 was cultivated in Luria-Bertani (LB) broth overnight with 363 shaking (220 rpm) at 37℃. Bacterial cells were harvested from 1 ml culture via centrifugation at 364 10,000 rpm for 10 minutes. Genomic DNA was extracted using the QIAamp DNA Mini Kit 365 following the manufacturer's instructions (Qiagen, Hilden, Germany). The concentration and 366 quality of genomic DNA was determined by NanoDrop and agarose (0.8%) gel electrophoresis. To carry out the phylogenetic analysis, we downloaded all available complete genomes of P. (Table S3 , for reviewers' information only) and selected 72 representative non-386 complete genomes that are distributed in the 32 phylogenetic groups as defined in the NCBI. Single 387 nucleotide polymorphisms (SNPs) were collected using Parsnp with default parameters (48) and 388 that of PAO1 served as the reference. SNPs were then used to build a maximum likelihood tree in 389 MEGA (49) with the following parameters: Tamura-Nei substitution model, gamma rate 390 distribution among sites, Nearest-Neighbor-Interchange for tree inference options, a bootstrap 391 value 100, and initial tree was generated using the Neighbor Joining method. Variants were called 392 using the Harvest tools (48) and annotated using SnpEff (50). 395 Resistance Gene Identifiers (RGI) from the Comprehensive Antibiotic Resistance Database Variants of all predicted antibiotic resistance genes were collected from the annotation with SnpEff 402 (50) using PAO1 as the reference. SNPs that cause non-synonymous mutations and gaps less than 403 6 bp were also identified and summarized. 406 RNA extraction, quality control, and RNA-Seq were performed in PA154197 and the reference 407 strain PAO1 with three biological replicates following our previous descriptions (44). Stranded libraries for all RNA samples were constructed using Kapa Biosystems RNA library preparation 0.5 ml of LB broth in 5 mL round bottom polypropylene Falcon tubes (final cell density as 0.1) 454 and incubated statically at 37 o C for 24 or 48 h to allow biofilm formation. After removing the 455 medium, the biofilms formed at the bottom of the tubes were gently washed with phosphate 456 buffered saline (PBS) three times to remove residual planktonic cells. The tubes were then air-457 dried and stained with 0.1% crystal violet for 15 min at room temperature. After washing the tubes 458 three times with sterile distilled water to remove excess dye molecules, biofilms were dissolved in 459 150 μl of 30% acetic acid and the optical density (OD) was measured at 595 nm using a 96-well 460 plate spectrometer reader. All experiments were performed in triplicates.
394
Identifications of antibiotic resistance genes (ARG) and mutations therein
RNA-seq
462
Nematode killing assay 463 To examine the virulence and pathogenesis of PA154197 compared with PAO1, fast and slow 464 killing kinetics of Caenorhabditis elegans (C. elegans) were performed with slight modification 465 (60). (1) Fast killing assay. Preparation of the killing plates can be divided into two steps. ⅰ) 100 466 μL of overnight culture of PA154197 or PAO1 were spread onto 3.5 cm LB agar plates and 467 incubated at 25 o C for 2 days to produce the toxins. ⅱ) Lawn of PA154197 or PAO1 was scraped 468 from LB agar plates containing the toxins completely using a sterile L spreader. C. elegans strain 469 N2 were synchronized by isolating eggs from gravid adults and plating eggs on to lawns of E. coli 470 OP50 on NGM [0.25% peptone, 0.3% NaCl, 2% agar, 5 μg/ml cholesterol, 1 mM MgSO4, and 25 471 mM KH2PO4 (pH 6)] agar plates followed by incubation at 25 o C for 48-52 h to reach the L4 stage.
472
Each fast killing plate was seeded with 20-30 worms. Plates were incubated at 25°C and scored 473 every 4-6 h. A worm was considered to be dead when it no longer responded to touch. (2) Slow 474 killing assay. The procedure was similar as fast killing assay except the preparation of killing plates.
475
For slow killing plates, lawn of PA154197 or PAO1 was not moved away. All experiments were 476 performed in triplicates.
478
Pyoverdine (PVD) production assay 479 The siderophore pyoverdine is observed under UV light as a fluorescent zone around the colony 480 (61). Fresh single colonies of PA154197 and PAO1 were inoculated in LB medium overnight at 481 37 °C with 220-rpm agitation. Following diluting overnight culture to 1×10 9 CFU/ml with fresh 482 LB medium, 10 μl cell suspension was then spotted on a LB agar plate. The plate was incubated 483 at 37 °C for 16-20 h. Fluorescent PVD was visualized and imaged under UV light. The authors do not have conflict of interests to declare. Table S3 and PA15419 is highlighted in red. 
